Who will benefit from DNase?

Pediatr Pulmonol. 1999 Jan;27(1):3-4. doi: 10.1002/(sici)1099-0496(199901)27:1<3::aid-ppul2>3.0.co;2-a.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adult
  • Chronic Disease
  • Ciliary Motility Disorders / complications
  • Ciliary Motility Disorders / drug therapy*
  • Deoxyribonuclease I / therapeutic use*
  • Expectorants / therapeutic use*
  • Humans
  • Infant
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins / therapeutic use
  • Respiratory Function Tests
  • Respiratory Tract Infections / drug therapy*
  • Respiratory Tract Infections / etiology
  • Treatment Outcome

Substances

  • Expectorants
  • Recombinant Proteins
  • DNASE1 protein, human
  • Deoxyribonuclease I